Lara Paracchini

1.1k total citations
17 papers, 537 citations indexed

About

Lara Paracchini is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lara Paracchini has authored 17 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lara Paracchini's work include Ovarian cancer diagnosis and treatment (6 papers), Cancer Genomics and Diagnostics (6 papers) and RNA modifications and cancer (3 papers). Lara Paracchini is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Cancer Genomics and Diagnostics (6 papers) and RNA modifications and cancer (3 papers). Lara Paracchini collaborates with scholars based in Italy, United States and Australia. Lara Paracchini's co-authors include Sergio Marchini, Maurizio D’Incalci, Luca Beltrame, Laura Mannarino, Ilaria Craparotta, Roberta Frapolli, Carlos M. Galmarini, Paola Allavena, Alberto Mantovani and Cristina Belgiovine and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and Critical Care Medicine.

In The Last Decade

Lara Paracchini

15 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lara Paracchini Italy 10 220 167 138 90 85 17 537
Regina Berger Austria 10 171 0.8× 75 0.4× 124 0.9× 41 0.5× 46 0.5× 28 445
Leonid L. Nikitenko United Kingdom 16 416 1.9× 157 0.9× 248 1.8× 37 0.4× 65 0.8× 22 801
Elsa Vanhecke France 7 281 1.3× 92 0.6× 224 1.6× 87 1.0× 13 0.2× 8 620
Stef van Lieshout Netherlands 7 243 1.1× 160 1.0× 91 0.7× 71 0.8× 9 0.1× 11 519
Islay Steele United Kingdom 15 291 1.3× 116 0.7× 203 1.5× 61 0.7× 29 0.3× 20 655
Sigve Nakken Norway 14 354 1.6× 127 0.8× 115 0.8× 80 0.9× 7 0.1× 40 640
Katrina L. Watson Canada 11 300 1.4× 226 1.4× 172 1.2× 24 0.3× 54 0.6× 18 642
Daisong Wang China 9 367 1.7× 84 0.5× 245 1.8× 48 0.5× 19 0.2× 15 640
Minhao Yu China 17 461 2.1× 296 1.8× 226 1.6× 66 0.7× 7 0.1× 39 779

Countries citing papers authored by Lara Paracchini

Since Specialization
Citations

This map shows the geographic impact of Lara Paracchini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Paracchini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Paracchini more than expected).

Fields of papers citing papers by Lara Paracchini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Paracchini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Paracchini. The network helps show where Lara Paracchini may publish in the future.

Co-authorship network of co-authors of Lara Paracchini

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Paracchini. A scholar is included among the top collaborators of Lara Paracchini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Paracchini. Lara Paracchini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ceresoli, Giovanni Luca, Laura Mannarino, Lara Paracchini, & Federica Grosso. (2024). Pleural mesothelioma: Long-term progression-free survival with Tumor Treating Fields (TTFields) therapy case reports. SHILAP Revista de lepidopterología. 17. 100342–100342.
2.
3.
Mannarino, Laura, Nicolò Panini, Lara Paracchini, et al.. (2022). Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulations. Cell Death and Disease. 13(7). 612–612. 4 indexed citations
4.
Paracchini, Lara, Laura Mannarino, Luca Beltrame, et al.. (2022). Targeted Mutational Analysis of Circulating Tumor DNA to Decipher Temporal Heterogeneity of High-Grade Serous Ovarian Cancer. Cancers. 14(15). 3697–3697. 8 indexed citations
5.
Paracchini, Lara, Maurizio D’Incalci, & Sergio Marchini. (2021). Liquid Biopsy in the Clinical Management of High-Grade Serous Epithelial Ovarian Cancer—Current Use and Future Opportunities. Cancers. 13(10). 2386–2386. 10 indexed citations
6.
Paracchini, Lara, Luca Beltrame, Tommaso Grassi, et al.. (2020). Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer. Clinical Cancer Research. 27(9). 2549–2559. 38 indexed citations
7.
Paracchini, Lara, Chiara Pesenti, Martina Delle Marchette, et al.. (2020). Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis. JAMA Network Open. 3(7). e207566–e207566. 13 indexed citations
8.
Calura, Enrica, Lara Paracchini, Paolo Martini, et al.. (2019). Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study. Cells. 8(12). 1554–1554. 9 indexed citations
9.
Paracchini, Lara, Luca Beltrame, Lucia Boeri, et al.. (2018). Exome sequencing in an Italian family with Alzheimer’s disease points to a role for seizure-related gene 6 (SEZ6) rare variant R615H. Alzheimer s Research & Therapy. 10(1). 106–106. 9 indexed citations
10.
Belgiovine, Cristina, Ezia Bello, Manuela Liguori, et al.. (2017). Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models. British Journal of Cancer. 117(5). 628–638. 119 indexed citations
11.
Iori, Valentina, Anand M. Iyer, Teresa Ravizza, et al.. (2016). Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy. Neurobiology of Disease. 99. 12–23. 141 indexed citations
12.
Mannarino, Laura, Lara Paracchini, Ilaria Craparotta, et al.. (2016). A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia. The Pharmacogenomics Journal. 18(1). 56–63. 8 indexed citations
14.
Paracchini, Lara, Laura Mannarino, Ilaria Craparotta, et al.. (2016). Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies. Oncotarget. 12(24). 2404–2417. 20 indexed citations
15.
Pischiutta, Francesca, Laura Brunelli, Antonietta Rosa Silini, et al.. (2016). Protection of Brain Injury by Amniotic Mesenchymal Stromal Cell-Secreted Metabolites. Critical Care Medicine. 44(11). e1118–e1131. 58 indexed citations
16.
Dossi, Romina, Roberta Frapolli, Silvana Di Giandomenico, et al.. (2014). Antiangiogenic activity of trabectedin in myxoid liposarcoma: Involvement of host TIMP‐1 and TIMP‐2 and tumor thrombospondin‐1. International Journal of Cancer. 136(3). 721–729. 48 indexed citations
17.
Romano, Michela, Anna Gallì, Nicolò Panini, et al.. (2014). 48 Trabectedin and lurbinectedin are effective against leukemic cells derived from patients affected by chronic and juvenile myelomonocytic leukemia. European Journal of Cancer. 50. 21–21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026